Login / Signup

The small molecule CBR-5884 inhibits the Candida albicans phosphatidylserine synthase.

Yue ZhouGregory A PhelpsMikayla M MangrumJemma McLeishElise K PhillipsJinchao LouChristelle F AncajasJeffrey M RybakPeter M OelkersRichard E LeeMichael D BestTodd B Reynolds
Published in: mBio (2024)
value of 1,550 ± 245.6 nM and, thus, has the potential for development into a new class of antifungals targeting PS synthase.
Keyphrases
  • candida albicans
  • small molecule
  • biofilm formation
  • protein protein
  • photodynamic therapy
  • cancer therapy
  • human health
  • escherichia coli
  • drug delivery
  • risk assessment
  • light emitting